Sunrise Medical, Inc. Sustainability Profile
Sunrise Medical, Inc., a leading name in the mobility and rehabilitation industry, is headquartered in the United States. Founded in 1983, the company has established itself as a pioneer in designing and manufacturing high-quality mobility solutions, including wheelchairs, power chairs, and seating systems. With a strong presence in North America, Europe, and Asia, Sunrise Medical is committed to enhancing the quality of life for individuals with mobility challenges. The company’s core products, such as the Quickie and Jazzy brands, are renowned for their innovative designs and advanced technology, setting them apart in the competitive market. Sunrise Medical has achieved significant milestones, including numerous industry awards for product excellence and customer satisfaction. As a trusted partner in the healthcare sector, Sunrise Medical continues to lead the way in providing exceptional mobility solutions tailored to individual needs.
DitchCarbon Score
How does Sunrise Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunrise Medical, Inc.'s score of 24 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sunrise Medical, Inc.'s reported carbon emissions
Sunrise Medical, Inc., headquartered in the US, has set ambitious climate commitments to address its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established significant reduction targets through the Science Based Targets initiative (SBTi). Sunrise GmbH, a related entity, has committed to reducing its absolute Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 51% by 2032, using 2022 as the base year. Additionally, it aims to achieve a 30% reduction in absolute Scope 3 emissions within the same timeframe. These targets align with the global goal of limiting temperature rise to 1.5°C, demonstrating a strong commitment to sustainability and climate action. As of now, Sunrise Medical, Inc. does not report specific emissions figures, but its long-term reduction targets reflect a proactive approach to mitigating climate impact. The company is not currently committed to net-zero emissions but continues to work towards substantial GHG reductions in its operations.
How Carbon Intensive is Sunrise Medical, Inc.'s Industry?
How Carbon Intensive is Sunrise Medical, Inc.'s Location?
Sunrise Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sunrise Medical, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
